These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 32126587)

  • 1. Molecular imaging of extracellular matrix proteins with targeted probes using magnetic resonance imaging.
    Salarian M; Ibhagui OY; Yang JJ
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2020 Jul; 12(4):e1622. PubMed ID: 32126587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycoconjugate probes and targets for molecular imaging using magnetic resonance.
    Geraldes CF; Djanashvili K; Peters JA
    Future Med Chem; 2010 Mar; 2(3):409-25. PubMed ID: 21426175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein MRI Contrast Agents as an Effective Approach for Precision Molecular Imaging.
    Li D; Kirberger M; Qiao J; Gui Z; Xue S; Pu F; Jiang J; Xu Y; Tan S; Salarian M; Ibhagui O; Hekmatyar K; Yang JJ
    Invest Radiol; 2024 Feb; 59(2):170-186. PubMed ID: 38180819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting the Extracellular Matrix in Abdominal Aortic Aneurysms Using Molecular Imaging Insights.
    Adams L; Brangsch J; Hamm B; Makowski MR; Keller S
    Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33799971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein-targeted gadolinium-based magnetic resonance imaging (MRI) contrast agents: design and mechanism of action.
    Caravan P
    Acc Chem Res; 2009 Jul; 42(7):851-62. PubMed ID: 19222207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Towards the Molecular Imaging of Prostate Cancer Biomarkers Using Protein-based MRI Contrast Agents.
    Pu F; Xue S; Qiao J; Patel A; Yang JJ
    Curr Protein Pept Sci; 2016; 17(6):519-33. PubMed ID: 26721404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted probes for cardiovascular MRI.
    Uppal R; Caravan P
    Future Med Chem; 2010 Mar; 2(3):451-70. PubMed ID: 20539821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concurrent Molecular Magnetic Resonance Imaging of Inflammatory Activity and Extracellular Matrix Degradation for the Prediction of Aneurysm Rupture.
    Brangsch J; Reimann C; Kaufmann JO; Adams LC; Onthank DC; Thöne-Reineke C; Robinson SP; Buchholz R; Karst U; Botnar RM; Hamm B; Makowski MR
    Circ Cardiovasc Imaging; 2019 Mar; 12(3):e008707. PubMed ID: 30871334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted Molecular Iron Oxide Contrast Agents for Imaging Atherosclerotic Plaque.
    Evans RJ; Lavin B; Phinikaridou A; Chooi KY; Mohri Z; Wong E; Boyle JJ; Krams R; Botnar R; Long NJ
    Nanotheranostics; 2020; 4(4):184-194. PubMed ID: 32637296
    [No Abstract]   [Full Text] [Related]  

  • 10. MRI probes for sensing biologically relevant metal ions.
    Bonnet CS; Tóth E
    Future Med Chem; 2010 Mar; 2(3):367-84. PubMed ID: 21426172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and
    Ma XH; Wang S; Liu SY; Chen K; Wu ZY; Li DF; Mi YT; Hu LB; Chen ZW; Zhao XM
    World J Gastroenterol; 2019 Jun; 25(24):3030-3043. PubMed ID: 31293339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of the hepatic tumor extracellular matrix using elastin-specific molecular magnetic resonance imaging in an experimental rabbit cancer model.
    Keller S; Borde T; Brangsch J; Reimann C; Kader A; Schulze D; Buchholz R; Kaufmann JO; Karst U; Schellenberger E; Hamm B; Makowski MR
    Sci Rep; 2020 Nov; 10(1):20785. PubMed ID: 33247185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular magnetic resonance imaging of atherosclerotic vessel wall disease.
    Nörenberg D; Ebersberger HU; Diederichs G; Hamm B; Botnar RM; Makowski MR
    Eur Radiol; 2016 Mar; 26(3):910-20. PubMed ID: 26139316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peptide-Conjugated MRI Probe Targeted to Netrin-1, a Novel Metastatic Breast Cancer Biomarker.
    Moreau C; Lukačević T; Pallier A; Sobilo J; Aci-Sèche S; Garnier N; Même S; Tóth É; Lacerda S
    Bioconjug Chem; 2024 Feb; 35(2):265-275. PubMed ID: 38340041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular magnetic resonance contrast agents for the detection of cancer: past and present.
    Bogdanov A; Mazzanti ML
    Semin Oncol; 2011 Feb; 38(1):42-54. PubMed ID: 21362515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular imaging of the extracellular matrix in the context of atherosclerosis.
    Reimann C; Brangsch J; Colletini F; Walter T; Hamm B; Botnar RM; Makowski MR
    Adv Drug Deliv Rev; 2017 Apr; 113():49-60. PubMed ID: 27639968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular Probes for Imaging Fibrosis and Fibrogenesis.
    Désogère P; Montesi SB; Caravan P
    Chemistry; 2019 Jan; 25(5):1128-1141. PubMed ID: 30014529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Magnetic nanoparticles as both imaging probes and therapeutic agents.
    Lacroix LM; Ho D; Sun S
    Curr Top Med Chem; 2010; 10(12):1184-97. PubMed ID: 20388109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design of a novel class of protein-based magnetic resonance imaging contrast agents for the molecular imaging of cancer biomarkers.
    Xue S; Qiao J; Pu F; Cameron M; Yang JJ
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2013; 5(2):163-79. PubMed ID: 23335551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biosynthetic molecular imaging probe for tumor-targeted dual-modal fluorescence/magnetic resonance imaging.
    Zhao H; Zhao H; Jiao Y; Zhu Y; Liu C; Li F; Wang Y; Gu Z; Yang D
    Biomaterials; 2020 Oct; 256():120220. PubMed ID: 32736168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.